Literature DB >> 14754614

Second hit mutations in the RTK/RAS signaling pathway in acute myeloid leukemia with inv(16).

Peter J M Valk, David T Bowen, Marion E Frew, Anne C Goodeve, Bob Löwenberg, John T Reilly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14754614

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  KIT with D816 mutations cooperates with CBFB-MYH11 for leukemogenesis in mice.

Authors:  Ling Zhao; Jan J Melenhorst; Lemlem Alemu; Martha Kirby; Stacie Anderson; Maggie Kench; Shelley Hoogstraten-Miller; Lauren Brinster; Yasuhiko Kamikubo; D Gary Gilliland; P Paul Liu
Journal:  Blood       Date:  2011-12-07       Impact factor: 22.113

2.  Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling.

Authors:  Roel G W Verhaak; Bas J Wouters; Claudia A J Erpelinck; Saman Abbas; H Berna Beverloo; Sanne Lugthart; Bob Löwenberg; Ruud Delwel; Peter J M Valk
Journal:  Haematologica       Date:  2008-10-06       Impact factor: 9.941

3.  Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value.

Authors:  Marta Pratcorona; Saman Abbas; Mathijs A Sanders; Jasper E Koenders; François G Kavelaars; Claudia A J Erpelinck-Verschueren; Annelieke Zeilemakers; Bob Löwenberg; Peter J M Valk
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

4.  The genomic landscape of core-binding factor acute myeloid leukemias.

Authors:  Zachary J Faber; Xiang Chen; Amanda Larson Gedman; Kristy Boggs; Jinjun Cheng; Jing Ma; Ina Radtke; Jyh-Rong Chao; Michael P Walsh; Guangchun Song; Anna K Andersson; Jinjun Dang; Li Dong; Yu Liu; Robert Huether; Zhongling Cai; Heather Mulder; Gang Wu; Michael Edmonson; Michael Rusch; Chunxu Qu; Yongjin Li; Bhavin Vadodaria; Jianmin Wang; Erin Hedlund; Xueyuan Cao; Donald Yergeau; Joy Nakitandwe; Stanley B Pounds; Sheila Shurtleff; Robert S Fulton; Lucinda L Fulton; John Easton; Evan Parganas; Ching-Hon Pui; Jeffrey E Rubnitz; Li Ding; Elaine R Mardis; Richard K Wilson; Tanja A Gruber; Charles G Mullighan; Richard F Schlenk; Peter Paschka; Konstanze Döhner; Hartmut Döhner; Lars Bullinger; Jinghui Zhang; Jeffery M Klco; James R Downing
Journal:  Nat Genet       Date:  2016-10-31       Impact factor: 38.330

5.  Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling.

Authors:  John Anto Pulikkan; Dmitri Madera; Liting Xue; Paul Bradley; Sean Francis Landrette; Ya-Huei Kuo; Saman Abbas; Lihua Julie Zhu; Peter Valk; Lucio Hernán Castilla
Journal:  Blood       Date:  2012-05-21       Impact factor: 22.113

6.  FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia.

Authors:  Hyung-Gyoon Kim; Kyoko Kojima; C Scott Swindle; Claudiu V Cotta; Yongliang Huo; Vishnu Reddy; Christopher A Klug
Journal:  Blood       Date:  2007-10-29       Impact factor: 22.113

Review 7.  Imaging findings in recurrent extramedullary leukaemias.

Authors:  M Arrigan; L Smyth; M Harmon; C Flynn; N Sheehy
Journal:  Cancer Imaging       Date:  2013-02-24       Impact factor: 3.909

8.  High levels of the adhesion molecule CD44 on leukemic cells generate acute myeloid leukemia relapse after withdrawal of the initial transforming event.

Authors:  R Quéré; S Andradottir; A C M Brun; R A Zubarev; G Karlsson; K Olsson; M Magnusson; J Cammenga; S Karlsson
Journal:  Leukemia       Date:  2010-11-30       Impact factor: 11.528

9.  Analysis of RAS gene mutations in cytogenetically normal de novo acute myeloid leukemia patients reveals some novel alterations.

Authors:  Afia Muhammad Akram; Asma Chaudhary; Humera Kausar; Fayez Althobaiti; Afshan Syed Abbas; Zawar Hussain; Naz Fatima; Erum Zafar; Wajiha Asif; Umair Afzal; Zoufishan Yousaf; Amjad Zafar; Steve M Harakeh; Samina Qamer
Journal:  Saudi J Biol Sci       Date:  2021-05-06       Impact factor: 4.219

10.  A case of therapy-related acute myeloid leukemia with inv(16)(p13.1q22) after single low-dose iodine-131 treatment for thyroid cancer.

Authors:  Ji Hun Jeong; Jeong Yeal Ahn; Soon Ho Park; Mi Jung Park; Kyung Hee Kim; Jun Shik Hong
Journal:  Korean J Hematol       Date:  2012-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.